POLYACTIVA

PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.
POLYACTIVA
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2009-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.polyactiva.com
Total Employee:
11+
Status:
Active
Contact:
61 3 9657 0700
Email Addresses:
[email protected]
Total Funding:
12.96 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network Font Awesome Organization Schema Sitelinks Search Box
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medical Research Future Fund (MRFF)
Medical Research Future Fund (MRFF) investment in Grant - PolyActiva
Brandon Capital
Brandon Capital investment in Grant - PolyActiva
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Series B - PolyActiva
Yuuwa Capital
Yuuwa Capital investment in Series B - PolyActiva
Brandon Capital
Brandon Capital investment in Series B - PolyActiva
State Government of Victoria
State Government of Victoria investment in Series A - PolyActiva
Official Site Inspections
http://www.polyactiva.com
- Host name: 45-79-237-164.ip.linodeusercontent.com
- IP address: 45.79.237.164
- Location: Fremont United States
- Latitude: 37.5625
- Longitude: -122.0004
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94536

More informations about "PolyActiva"
About - PolyActiva
Visionary Leadership PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and โฆSee details»
Home - PolyActiva
PolyActiva has showcased their Phase 2 clinical data for their lead candidate PA5108 Ocular Implant in glaucoma patients. Patients received continuous therapy for intraocular pressure โฆSee details»
PolyActiva - Crunchbase Company Profile & Funding
Organization. PolyActiva . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... PolyActiva has โฆSee details»
Team - PolyActiva
He joined PolyActiva in 2010 and as the Head of Chemistry, Pipeline Innovation and IP he oversees the team responsible for the innovation, optimization, development and manufacture โฆSee details»
PolyActiva - LinkedIn
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to โฆSee details»
POLYACTIVA PTY LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for POLYACTIVA PTY LTD of NOTTING HILL, VICTORIA. Get the latest business insights from Dun & Bradstreet.See details»
PolyActiva - Org Chart, Teams, Culture & Jobs - The Org
PolyActiva is an Australian-based biotechnology company that has developed a platform technology to deliver drugs to specific sites in the body. The polymeric prodrugs can take โฆSee details»
PolyActiva 2025 Company Profile: Valuation, Funding & Investors
PolyActiva General Information Description. Developer of drug-polymer conjugates designed for site-specific drug delivery from medical device components. The company offers a delivery โฆSee details»
PolyActiva - Contacts, Employees, Board Members, Advisors
Organization. PolyActiva . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board โฆSee details»
PolyActiva Company Profile - Office Locations, Competitors ... - Craft
PolyActiva has 5 employees at their 1 location and $11.38 m in total funding,. See insights on PolyActiva including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
PolyActiva โ Brandon BioCatalyst
PolyActivaโs delivery technology is also very well suited for site specific drug delivery to other sites of the body. The process by which PolyActiva manufactures its ocular implants is robust and โฆSee details»
PolyActiva - Research and Development - The Org
The Research and Development team at PolyActiva focuses on creating and refining polymeric prodrugs for targeted drug delivery systems. They work on developing and optimizing drug โฆSee details»
PolyActiva Pty Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
PolyActiva Pty Ltd, a clinical-stage Australian biopharmaceutical company focused on developing unique biodegradable ocular implants with sustained drug delivery for patients suffering from โฆSee details»
PolyActiva - VentureRadar
PolyActivaโs platform technology is used to deliver drugs to specific sites in the body with control over the rate of drug delivery for up to 12-months. The technology involves formation of a โฆSee details»
PolyActiva - Funding, Financials, Valuation & Investors - Crunchbase
PolyActiva develops products that enable drug release from medical devices. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. โฆSee details»
PolyActiva - Brandon Capital
San Francisco. Brandon Capital LLC. 1 Letterman Ave, Suite C3-330. San Francisco, CA 94129. Phone +61 3 9657 0700. Email: [email protected]See details»
Working at PolyActiva - Glassdoor
Glassdoor gives you an inside look at what it's like to work at PolyActiva, including salaries, reviews, office photos, and more. This is the PolyActiva company profile. All content is posted โฆSee details»
Technology - PolyActiva
PreziaTM Technology For development of best-in-class ocular implants that deliver the right amount of drug, for the right period. Our technology is based on extensive scientific research โฆSee details»
Glaucoma Implant Positive Trial Data | Glaucoma Australia
"PolyActivaโs proprietary implant is designed to address the long-standing challenge of poor patient adherence with traditional eye drop therapy" Seventeen participants were recruited to โฆSee details»
PolyActiva reports promising clinical trial results for its 6-month ...
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to โฆSee details»